CHF718 pMDI with HFA-134a Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

Chiesi Farmaceutici S.p.A.1

Indications

Asthma1

Other1 trial

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.